Emma Walker (Paediatrics trainee) , Wesley Hayes (Consultant Paediatric Nephrologist) , Detlef Bockenhauer (Professor and Consultant Paediatric Nephrologist)
{"title":"Inherited non-FGF23-mediated phosphaturic disorders: A kidney-centric review","authors":"Emma Walker (Paediatrics trainee) , Wesley Hayes (Consultant Paediatric Nephrologist) , Detlef Bockenhauer (Professor and Consultant Paediatric Nephrologist)","doi":"10.1016/j.beem.2023.101843","DOIUrl":null,"url":null,"abstract":"<div><p><span>Phosphate is freely filtered by the glomerulus and reabsorbed exclusively in the proximal tubule by two key transporters, NaPiIIA and NaPiIIC, encoded by </span><em>SLC34A1</em> and <span><em>SLC34A3</em></span><span><span><span>, respectively. Regulation of these transporters occurs primarily through the hormone FGF23 and, to a lesser degree, </span>PTH. Consequently, inherited non-FGF23 mediated phosphaturic disorders are due to generalised proximal </span>tubular dysfunction, loss-of-function variants in </span><em>SLC34A1</em> or <em>SLC34A3</em><span> or excess PTH signalling. The corresponding disorders are Renal Fanconi Syndrome<span><span>, Infantile Hypercalcaemia<span><span> type 2, Hereditary Hypophosphataemic Rickets with </span>Hypercalciuria and </span></span>Familial Hyperparathyroidism<span>. Several inherited forms of Fanconi renotubular syndrome (FRTS) have also been described with the underlying genes encoding for GATM, EHHADH, HNF4A and NDUFAF6. Here, we will review their pathophysiology<span><span><span>, clinical manifestations and the implications for treatment<span> from a kidney-centric perspective, focussing on those disorders caused by dysfunction of renal phosphate transporters. Moreover, we will highlight specific </span></span>genetic aspects, as the availability of large </span>population genetic databases has raised doubts about some of the originally proposed gene-disease associations concerning phosphate transporters or their associated proteins.</span></span></span></span></p></div>","PeriodicalId":8810,"journal":{"name":"Best practice & research. Clinical endocrinology & metabolism","volume":"38 2","pages":"Article 101843"},"PeriodicalIF":6.1000,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Best practice & research. Clinical endocrinology & metabolism","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1521690X23001173","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Phosphate is freely filtered by the glomerulus and reabsorbed exclusively in the proximal tubule by two key transporters, NaPiIIA and NaPiIIC, encoded by SLC34A1 and SLC34A3, respectively. Regulation of these transporters occurs primarily through the hormone FGF23 and, to a lesser degree, PTH. Consequently, inherited non-FGF23 mediated phosphaturic disorders are due to generalised proximal tubular dysfunction, loss-of-function variants in SLC34A1 or SLC34A3 or excess PTH signalling. The corresponding disorders are Renal Fanconi Syndrome, Infantile Hypercalcaemia type 2, Hereditary Hypophosphataemic Rickets with Hypercalciuria and Familial Hyperparathyroidism. Several inherited forms of Fanconi renotubular syndrome (FRTS) have also been described with the underlying genes encoding for GATM, EHHADH, HNF4A and NDUFAF6. Here, we will review their pathophysiology, clinical manifestations and the implications for treatment from a kidney-centric perspective, focussing on those disorders caused by dysfunction of renal phosphate transporters. Moreover, we will highlight specific genetic aspects, as the availability of large population genetic databases has raised doubts about some of the originally proposed gene-disease associations concerning phosphate transporters or their associated proteins.
期刊介绍:
Best Practice & Research Clinical Endocrinology & Metabolism is a serial publication that integrates the latest original research findings into evidence-based review articles. These articles aim to address key clinical issues related to diagnosis, treatment, and patient management.
Each issue adopts a problem-oriented approach, focusing on key questions and clearly outlining what is known while identifying areas for future research. Practical management strategies are described to facilitate application to individual patients. The series targets physicians in practice or training.